Straits Times Index
3,287.75 -5.38 (-0.16%) S&P 500
5,003.06 -68.57 (-1.35%) Dow
37,879.01 -581.91 (-1.51%) Nasdaq
15,417.48 -295.27 (-1.88%) Bitcoin USD
63,288.14 -2,856.57 (-4.32%) CMC Crypto 200
1,365.80 -16.77 (-1.21%)
Ekso Bionics Holdings, Inc. (0IFR.L)
| Previous close | 1.3107 |
| Open | 0.0000 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 0.0000 - 0.0000 |
| 52-week range | |
| Volume | |
| Avg. volume | 1,151 |
| Market cap | 850,369 |
| Beta (5Y monthly) | 1.64 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.9260 |
| Earnings date | 29 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireEkso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024
SAN RAFAEL, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the first quarter 2024 after the close of trading on Monday, April 29, 2024. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments. A live webca
- GlobeNewswire
Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal
SAN RAFAEL, Calif., April 12, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today announced that the Pricing, Data Analysis, and Coding (“PDAC”) contractor for the Centers for Medicare & Medicaid Services (“CMS”) has determined a final payment level of $91,031.93 for Medicare reimbursement of the Ekso Indego Personal, which took effect on April 1, 2024. As previou
Simply Wall St.Ekso Bionics Holdings Full Year 2023 Earnings: EPS Misses Expectations
Ekso Bionics Holdings ( NASDAQ:EKSO ) Full Year 2023 Results Key Financial Results Revenue: US$18.3m (up 42% from FY...
